• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早产儿视网膜病变筛查在≥30 孕周时:尿 NTpro-BNP 的表现。

Retinopathy of prematurity screening at ≥30 weeks: urinary NTpro-BNP performance.

机构信息

Newcastle Neonatal Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.

出版信息

Acta Paediatr. 2018 Oct;107(10):1722-1725. doi: 10.1111/apa.14354. Epub 2018 Apr 30.

DOI:10.1111/apa.14354
PMID:29617052
Abstract

AIM

Urinary N-terminal B-type natriuretic peptide NTproBNP levels are associated with the development of retinopathy of prematurity (ROP) in infants <30 weeks of gestation. The incidence of ROP in more mature infants who meet other ROP screening criteria is very low. We therefore aimed to test whether urinary NTproBNP predicted ROP development in these infants.

METHODS

Prospective observational study in 151 UK infants ≥30 + 0 weeks of gestation but also <32 weeks of gestation and/or <1501 g, to test the hypothesis that urinary NTproBNP levels on day of life (DOL) 14 and 28 were able to predict ROP development.

RESULTS

Urinary NTproBNP concentrations on day 14 and day 28 of life did not differ between infants with and without ROP (medians 144 vs 128 mcg/mL, respectively, p = 0.86 on DOL 14 and medians 117 vs 94 mcg/mL, respectively, p = 0.64 on DOL28).

CONCLUSION

The association previously shown for infants <30 completed weeks between urinary NTproBNP and the development of ROP was not seen in more mature infants. Urinary NTproBNP does not appear helpful in rationalising direct ophthalmoscopic screening for ROP in more mature infants, and may suggest a difference in pathophysiology of ROP in this population.

摘要

目的

尿 N 端脑利钠肽前体 NTproBNP 水平与<30 周胎龄早产儿视网膜病变(ROP)的发生有关。符合其他 ROP 筛查标准的更成熟婴儿的 ROP 发生率非常低。因此,我们旨在测试尿 NTproBNP 是否可以预测这些婴儿的 ROP 发展。

方法

对 151 名英国婴儿进行前瞻性观察研究,胎龄≥30+0 周但<32 周且/或体重<1501g,以检验尿 NTproBNP 水平在第 14 天和第 28 天能否预测 ROP 发展的假设。

结果

有 ROP 和无 ROP 的婴儿在第 14 天和第 28 天的尿 NTproBNP 浓度没有差异(第 14 天分别为 144 与 128mcg/mL,p=0.86;第 28 天分别为 117 与 94mcg/mL,p=0.64)。

结论

先前在<30 周完全胎龄的婴儿中观察到的尿 NTproBNP 与 ROP 发生之间的关联,在更成熟的婴儿中并未出现。尿 NTproBNP 似乎无助于合理化对更成熟婴儿的 ROP 直接眼底镜筛查,并且可能表明该人群 ROP 的病理生理学存在差异。

相似文献

1
Retinopathy of prematurity screening at ≥30 weeks: urinary NTpro-BNP performance.早产儿视网膜病变筛查在≥30 孕周时:尿 NTpro-BNP 的表现。
Acta Paediatr. 2018 Oct;107(10):1722-1725. doi: 10.1111/apa.14354. Epub 2018 Apr 30.
2
N-terminal B-type natriuretic peptide urinary concentrations and retinopathy of prematurity.N 端 B 型利钠肽尿浓度与早产儿视网膜病变。
Pediatr Res. 2017 Dec;82(6):958-963. doi: 10.1038/pr.2017.179. Epub 2017 Aug 16.
3
Urinary N-terminal B-type natriuretic peptide predicts severe retinopathy of prematurity.尿 N 端 B 型利钠肽预测严重早产儿视网膜病变。
Pediatrics. 2011 Sep;128(3):e545-9. doi: 10.1542/peds.2011-0603. Epub 2011 Aug 8.
4
Vasoactive peptides as biomarkers for the prediction of retinopathy of prematurity.血管活性肽作为预测早产儿视网膜病变的生物标志物。
Pediatr Res. 2024 Jun;95(7):1868-1874. doi: 10.1038/s41390-024-03091-w. Epub 2024 Feb 24.
5
Screening for retinopathy of prematurity in China: a neonatal units-based prospective study.中国早产儿视网膜病变筛查:一项基于新生儿病房的前瞻性研究。
Invest Ophthalmol Vis Sci. 2013 Dec 19;54(13):8229-36. doi: 10.1167/iovs.13-12297.
6
Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.影响早产儿 N 端脑利钠肽前体水平的因素及其在动脉导管未闭血流动力学意义判断中的应用。
Eur J Pediatr. 2018 Apr;177(4):521-532. doi: 10.1007/s00431-018-3089-y. Epub 2018 Jan 19.
7
Incidence of retinopathy of prematurity in infants born before 27 weeks' gestation in Sweden.瑞典妊娠27周前出生婴儿的早产儿视网膜病变发病率。
Arch Ophthalmol. 2009 Oct;127(10):1315-9. doi: 10.1001/archophthalmol.2009.244.
8
Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study.早产儿视网膜病变改良筛查标准的制定:来自早产儿出生后生长和早产儿视网膜病变研究的初步结果。
JAMA Ophthalmol. 2018 Sep 1;136(9):1034-1040. doi: 10.1001/jamaophthalmol.2018.2753.
9
Validation of the Children's Hospital of Philadelphia Retinopathy of Prematurity (CHOP ROP) Model.费城儿童医院早产儿视网膜病变(CHOP ROP)模型的验证
JAMA Ophthalmol. 2017 Aug 1;135(8):871-877. doi: 10.1001/jamaophthalmol.2017.2295.
10
Screening for retinopathy of prematurity in infants born before 27 weeks' gestation in Sweden.在瑞典对妊娠27周前出生的婴儿进行早产儿视网膜病变筛查。
Arch Ophthalmol. 2011 Feb;129(2):167-72. doi: 10.1001/archophthalmol.2010.346.

引用本文的文献

1
Novel Potential Biomarkers for Retinopathy of Prematurity.早产儿视网膜病变的新型潜在生物标志物
Front Med (Lausanne). 2022 Feb 2;9:840030. doi: 10.3389/fmed.2022.840030. eCollection 2022.